Ming Xian - 26 May 2026 Form 4 Insider Report for MEDIFAST INC (MED)

Reporting relationship: Director
Issuer ticker: MED
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 19:31:18 UTC
Prior SEC filing: 26 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ James P. Maloney, attorney-in-fact

Key filing fact

Ming Xian filed Form 4 for MEDIFAST INC (MED) on 28 May 2026.

Key facts

This page summarizes Ming Xian's Form 4 filing for MEDIFAST INC (MED).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 May 2026, 19:31.

Change

Previous filing in this sequence was filed on 26 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001743879 Primary reporting owner

Xian Ming

Relationship: Director
Address: C/O MEDIFAST, INC., 1501 S. CLINTON STREET, SUITE 500, BALTIMORE
Signature: /s/ James P. Maloney, attorney-in-fact
Signature date: 28 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MED transaction Derivative

Restricted Stock Units (cash settled)

Award

Transaction value
Shares: +11,680
Change %: +36%
Price: $0.000000^*
Shares after: 43,823
Date: 26 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,680
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on May 26, 2027. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock on the date of vesting.